MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription

doi:10.3748/wjg.v25.i45.6619

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 45

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6797)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

383

WORD

213

HTML

2832

Figures (1-6)

394

Tables (1-1)

312

Sum=4134

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

892

Download

1771

Sum=2663

Dec 7, 2019 (publication date) through Feb 4, 2025

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Dec 7, 2019; 25(45): 6619-6633
Published online Dec 7, 2019. doi: 10.3748/wjg.v25.i45.6619

Full Size Figure Download Figure

Figure 1 The expression of microRNA-760 is decreased in gastric cancer. A: MicroRNA-760 (miR-760) expression in gastric cancer tissues; B: MiR-760 expression in MKN-45, AGS, and GES-1 cells; C and D: Dysregulation of miR-760 was related to overall survival and disease-free survival in GC patients. ^bP < 0.01. GC: Gastric cancer; MiR-760: MicroRNA-760.

Citation: Ge L, Wang Y, Duan QH, Liu SS, Liu GJ. MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription. World J Gastroenterol 2019; 25(45): 6619-6633
URL: https://www.wjgnet.com/1007-9327/full/v25/i45/6619.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i45.6619